Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study.
HIV
insomnia
patient reported outcomes measures
restless legs syndrome
sleep apnea syndromes
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
08
09
2020
accepted:
11
11
2020
entrez:
15
1
2021
pubmed:
16
1
2021
medline:
16
1
2021
Statut:
epublish
Résumé
Self-reported sleep quality is poor in persons with human immunodeficiency virus (PWH), but prior studies commonly used nonspecific questionnaires, investigated only single sleep disorders, or lacked human immunodeficiency virus (HIV)-negative controls. We addressed these limitations in the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Sleep Substudy by assessing PWH and HIV-negative controls for insomnia, restless legs syndrome (RLS), and sleep apnea (SA). Previously enrolled POPPY participants coenrolled in this substudy without regard to sleep symptoms. Participants completed validated sleep assessments including the Insomnia Severity Index questionnaire, International Restless Legs Syndrome Study Group questionnaire, and in-home, wrist-worn overnight oximetry. They also completed health-related quality of life questionnaires including 36-item Short Form (SF-36) and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep questionnaires. We enrolled 357 PWH (246 >50 years of age; 111 between 18 and 50 years) and 126 HIV-negative controls >50 years of age. Among PWH, criteria were met by 21% for insomnia, 13% for RLS, and 6% for SA. Compared with HIV-negative controls, PWH had a higher risk of insomnia (adjusted odds ratio, 5.3; 95% confidence interval, 2.2-12.9) but not RLS or SA. Compared with PWH without insomnia, those with insomnia reported significantly worse scores on all SF-36 and PROMIS components; fewer than 30% reported previous diagnosis or treatment for insomnia. Insomnia was more common in PWH, associated with worse health-related quality of life, and frequently undiagnosed. Further research should focus on the pathogenesis of insomnia in PWH and the development of effective screening and intervention strategies for this unique population.
Sections du résumé
BACKGROUND
BACKGROUND
Self-reported sleep quality is poor in persons with human immunodeficiency virus (PWH), but prior studies commonly used nonspecific questionnaires, investigated only single sleep disorders, or lacked human immunodeficiency virus (HIV)-negative controls. We addressed these limitations in the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Sleep Substudy by assessing PWH and HIV-negative controls for insomnia, restless legs syndrome (RLS), and sleep apnea (SA).
METHODS
METHODS
Previously enrolled POPPY participants coenrolled in this substudy without regard to sleep symptoms. Participants completed validated sleep assessments including the Insomnia Severity Index questionnaire, International Restless Legs Syndrome Study Group questionnaire, and in-home, wrist-worn overnight oximetry. They also completed health-related quality of life questionnaires including 36-item Short Form (SF-36) and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep questionnaires.
RESULTS
RESULTS
We enrolled 357 PWH (246 >50 years of age; 111 between 18 and 50 years) and 126 HIV-negative controls >50 years of age. Among PWH, criteria were met by 21% for insomnia, 13% for RLS, and 6% for SA. Compared with HIV-negative controls, PWH had a higher risk of insomnia (adjusted odds ratio, 5.3; 95% confidence interval, 2.2-12.9) but not RLS or SA. Compared with PWH without insomnia, those with insomnia reported significantly worse scores on all SF-36 and PROMIS components; fewer than 30% reported previous diagnosis or treatment for insomnia.
CONCLUSIONS
CONCLUSIONS
Insomnia was more common in PWH, associated with worse health-related quality of life, and frequently undiagnosed. Further research should focus on the pathogenesis of insomnia in PWH and the development of effective screening and intervention strategies for this unique population.
Identifiants
pubmed: 33447632
doi: 10.1093/ofid/ofaa561
pii: ofaa561
pmc: PMC7781463
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa561Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL131049
Pays : United States
Informations de copyright
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
Références
J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):609-16
pubmed: 23722610
J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):106-112
pubmed: 32452971
Sleep Breath. 2016 May;20(2):583-7
pubmed: 26354105
Behav Sleep Med. 2011 Dec 28;10(1):6-24
pubmed: 22250775
Int J Epidemiol. 2018 Oct 1;47(5):1391-1392e
pubmed: 29746638
AIDS Behav. 2018 Sep;22(9):2877-2887
pubmed: 29855973
Aging Dis. 2018 Dec 4;9(6):1010-1019
pubmed: 30574414
J Infect Dis. 2010 Jun 15;201(12):1788-95
pubmed: 20446848
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
J Psychiatr Res. 2006 Apr;40(3):273-9
pubmed: 16473570
Anesth Analg. 2012 May;114(5):993-1000
pubmed: 22366847
J Clin Sleep Med. 2012 Feb 15;8(1):67-75
pubmed: 22334812
AIDS Patient Care STDS. 2015 Nov;29(11):591-6
pubmed: 26376124
Chest. 2003 Nov;124(5):1694-701
pubmed: 14605037
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
Sleep Med. 2003 Mar;4(2):101-19
pubmed: 14592341
Lancet. 2005 Mar 19-25;365(9464):1046-53
pubmed: 15781100
Sleep. 2012 Jan 01;35(1):131-7
pubmed: 22215927
Int J STD AIDS. 2020 Sep;31(10):996-1003
pubmed: 32772688
Psychogeriatrics. 2018 May;18(3):155-165
pubmed: 29878472
Sleep Med Rev. 2010 Feb;14(1):69-82
pubmed: 19962922
J Antimicrob Chemother. 2015 Oct;70(10):2693-708
pubmed: 26203180
AIDS Rev. 2014 Jan-Mar;16(1):3-13
pubmed: 24522778
Neurology. 2016 Apr 12;86(15):1425-1432
pubmed: 26911637
Sleep. 2014 Apr 01;37(4):655-63
pubmed: 24899757
JAMA Intern Med. 2015 Sep;175(9):1461-72
pubmed: 26147487
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):260-5
pubmed: 9803968
Behav Sleep Med. 2020 Aug 12;:1-17
pubmed: 32781842
Curr Opin HIV AIDS. 2018 Mar;13(2):102-111
pubmed: 29278532
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Pharmacoeconomics. 1999 Feb;15(2):141-55
pubmed: 10351188
J Clin Epidemiol. 1988;41(4):313-21
pubmed: 3351539
J Neurol. 2007 Oct;254(10):1401-6
pubmed: 17934881
Sleep Med Clin. 2018 Mar;13(1):13-19
pubmed: 29412980
Behav Sleep Med. 2018 May-Jun;16(3):244-258
pubmed: 27362814
Sleep Med Clin. 2018 Mar;13(1):21-37
pubmed: 29412981
Clin Infect Dis. 2012 May;54(10):1485-94
pubmed: 22431801
Sleep. 2014 Mar 01;37(3):453-63
pubmed: 24587567
PLoS One. 2014 Jul 03;9(7):e99258
pubmed: 24991815
Biol Res Nurs. 2014 Apr;16(2):143-51
pubmed: 23460603
Med Care. 1995 Apr;33(4 Suppl):AS264-79
pubmed: 7723455
J Assoc Nurses AIDS Care. 2009 Jan-Feb;20(1):6-13
pubmed: 19118766
HIV Med. 2015 Feb;16(2):105-13
pubmed: 25230851